Search clinical trials for: contraceptive patch

Total 3916 results

Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Rhythmic Estradiol and Bone Health (REBEL)

Menopause | Osteoporosis Risk

Netherlands
Massachusetts General Hospital

Recruiting

The Role of Estrogen in the Neurobiology of Eating Disorders

Eating Disorders | Hypoestrogenemia

United States
Viatris Inc.

Completed

Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch

Contraception

Germany
Cedars-Sinai Medical Center

Completed

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

Hypothalamic Amenorrhea | Estrogen Deficiency | Cardiovascular Disease (CVD)

United States
Mayo Clinic

Completed

Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

Cardiovascular Risk Reduction

United States
Nemours Children's Clinic
Genentech, Inc.

Completed

Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism

Hypogonadism | Turner Syndrome | Premature Ovarian Failure

United States, Chile
Istanbul University - Cerrahpasa (IUC)
Turkish Menopause and Osteoporosis Society; Karakoy Rotary Club; Rebul Pharmacy

Completed

Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients

COVID-19 | Hormone Replacement Therapy

Turkey
Children's Hospital Medical Center, Cincinnati
Patty Brisben Foundation For Women's Sexual Health

Completed

Primary Ovarian Insufficiency: Phenotype and Optimal Treatment

Primary Ovarian Insufficiency

United States
Medical College of Wisconsin

Terminated

Coagulation and Fibrinolysis of Estradiol in Transwomen

Transgenderism | Clotting Disorder

United States
Organon and Co

Completed

A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)

Contraception
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group

Completed

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

HIV Infections | Pregnancy

United States, Puerto Rico
RemovAid AS
Karolinska Institutet; FHI 360; Mulago Hospital, Uganda

Completed

Safe Access: Trial With RemovAid Device

Removal of a Contraceptive Subdermal Implant

Uganda
Massachusetts General Hospital

Completed

Effects of Anorexia Nervosa on Peak Bone Mass

Anorexia Nervosa

United States
Massachusetts General Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes

Exercise-related Amenorrhea

United States
Bayer

Completed

US Ovulation Inhibition Study in Obese Women

Contraception

United States
Bayer

Completed

Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

Contraception

United States
Center for Epidemiology and Health Research, Germany
Gedeon Richter Plc.

Terminated

European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception (EURAS-CORA)

Contraception

Germany
Janssen Research & Development, LLC

Completed

A Study of New Transdermal Contraceptive Patch at End of Shelf Life and Currently Marketed EVRA at the Beginning of Shelf Life in Healthy Women

Healthy

Netherlands, Germany, Belgium
University of California, San Francisco

Completed

Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion

Abortion

United States
Massachusetts General Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa (1180)

Anorexia Nervosa | Osteoporosis

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA in Healthy Adult Women

Healthy

Belgium
Agile Therapeutics

Completed

Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females

Healthy

United States
Purdue Pharma LP

Completed

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

ECG Effects

United States
University Hospital, Angers

Unknown

Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer

Infertility | Embryo Transfer

France
University of Wisconsin, Madison
National Institute on Aging (NIA)

Completed

Alzheimer's Disease: Therapeutic Potential of Estrogen

Alzheimer Disease

United States
Massachusetts General Hospital
National Institute on Aging (NIA)

Completed

Aging and Estrogen on Cortical Function

Postmenopausal Symptoms | Memory Loss | Cognitive Changes

United States
Agile Therapeutics

Completed

Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers

Healthy

United States
Agile Therapeutics

Completed

Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System

Contraception

United States
Agile Therapeutics

Completed

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches (ATI-CL21)

Healthy
Nemours Children's Clinic
Eli Lilly and Company

Completed

Estrogen Treatment (Oral vs. Patches) in Turner Syndrome

Hypogonadism | Turner Syndrome | Premature Ovarian Failure

United States
Agile Therapeutics

Completed

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm (ATI-CL13)

Contraception

United States
Bayer

Completed

Russia/Ukraine Suppression of Ovarian Activity Study

Contraception

Russian Federation, Ukraine
Eunice Kennedy Shriver National Institute of Child...

Withdrawn

Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure

Premature Ovarian Failure

United States
Boston Medical Center

Completed

The Pharmacokinetics of 12 Week Continuous Patch Use

Pharmacokinetics

United States
University Hospital, Toulouse

Completed

Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route

Postmenopausal

France
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

Female Contraception | Contraception
Johnson & Johnson Pharmaceutical Research & Development...
Boston Collaborative Drug Surveillance Program

Completed

Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.

Female Contraception | Contraception | Fertility Control
Johnson & Johnson Pharmaceutical Research & Development...
Boston Collaborative Drug Surveillance Program

Completed

Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks

Female Contraception | Contraception
Health Decisions
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG) (CCN009)

Contraception

United States
Bayer

Completed

US Cycle Control and Blood Pressure Study

Contraception

United States
The Alfred
Stanley Medical Research Institute

Completed

A Definitive Estrogen Patch Study (ADEPT)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder(Not in Manic Phase)

Australia
Bayer

Completed

EU/LA Pearl Index Study - Transdermal Contraceptive Patch

Contraception

Italy, Spain, Australia, France, Germany, Argentina, Mexico, Chile
Bayer

Terminated

Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene

Contraception | Ovulation Inhibition

Germany
Bayer

Completed

Transdermal Contraceptive Patch - Endometrial Effects Study

Contraception

Germany
Bayer

Completed

FC Patch Low: Metabolism Study

Contraception

Germany
Bayer

Completed

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

Contraception

Netherlands, Germany
Royal Brompton & Harefield NHS Foundation Trust
Chelsea and Westminster NHS Foundation Trust; Imperial College Healthcare NHS...

Unknown

Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy (OPTIMISE)

Venous Thrombosis | Insulin Resistance

United Kingdom
Medprin Regenerative Medical Technologies Co.,...

Unknown

Study to Evaluate the Safety and Efficacy of Dural Repair Patch in Neurosurgical Repairs

Neurosurgical Repairs

China
Bayer

Completed

Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites

Contraception

Germany
Janssen-Cilag Farmaceutica Ltda.

Completed

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol

Contraception

Brazil, Mexico

Search clinical trials for: contraceptive patch

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations